JP2008526988A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526988A5 JP2008526988A5 JP2007551409A JP2007551409A JP2008526988A5 JP 2008526988 A5 JP2008526988 A5 JP 2008526988A5 JP 2007551409 A JP2007551409 A JP 2007551409A JP 2007551409 A JP2007551409 A JP 2007551409A JP 2008526988 A5 JP2008526988 A5 JP 2008526988A5
- Authority
- JP
- Japan
- Prior art keywords
- indol
- ylmethyl
- urea
- pyridin
- methoxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 claims 22
- 125000005843 halogen group Chemical group 0.000 claims 19
- 229910052739 hydrogen Inorganic materials 0.000 claims 19
- 239000001257 hydrogen Substances 0.000 claims 19
- 239000000126 substance Substances 0.000 claims 19
- 150000005829 chemical entities Chemical class 0.000 claims 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 18
- 108091000080 Phosphotransferase Proteins 0.000 claims 16
- -1 amino, aminocarbonyl Chemical group 0.000 claims 16
- 201000010099 disease Diseases 0.000 claims 16
- 102000020233 phosphotransferase Human genes 0.000 claims 16
- 238000000099 in vitro assay Methods 0.000 claims 15
- 125000001072 heteroaryl group Chemical group 0.000 claims 13
- 150000002431 hydrogen Chemical class 0.000 claims 13
- 125000001424 substituent group Chemical group 0.000 claims 12
- 150000001875 compounds Chemical class 0.000 claims 11
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims 10
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims 10
- 230000005764 inhibitory process Effects 0.000 claims 10
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 claims 6
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 claims 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims 6
- 125000004076 pyridyl group Chemical group 0.000 claims 6
- 125000003107 substituted aryl group Chemical group 0.000 claims 6
- 125000002252 acyl group Chemical group 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 230000033115 angiogenesis Effects 0.000 claims 5
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 206010036618 Premenstrual syndrome Diseases 0.000 claims 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 4
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 4
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 claims 3
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 208000002780 macular degeneration Diseases 0.000 claims 3
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 3
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 2
- ZXBFYBLSJMEBEP-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-(5-bromo-2-methoxyphenyl)urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 ZXBFYBLSJMEBEP-UHFFFAOYSA-N 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 206010014733 Endometrial cancer Diseases 0.000 claims 2
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 2
- 201000009273 Endometriosis Diseases 0.000 claims 2
- 230000002159 abnormal effect Effects 0.000 claims 2
- 230000005856 abnormality Effects 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000004064 dysfunction Effects 0.000 claims 2
- 208000031169 hemorrhagic disease Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 230000016087 ovulation Effects 0.000 claims 2
- 230000027758 ovulation cycle Effects 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 241000894007 species Species 0.000 claims 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- UBERZPIAQDYONQ-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-yl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C=1C=C2OCOC2=CC=1NC(=O)NC(C=1C=C2)=CC=CC=1N2CC1=CC=NC=C1 UBERZPIAQDYONQ-UHFFFAOYSA-N 0.000 claims 1
- XFERBKPZRBVADM-UHFFFAOYSA-N 1-(2-methoxy-5-phenylphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(C=2C=CC=CC=2)C=C1NC(=O)NC(C=1C=C2)=CC=CC=1N2CC1=CC=NC=C1 XFERBKPZRBVADM-UHFFFAOYSA-N 0.000 claims 1
- FPWGFVUWXYCRQH-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(OC)C(OC)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 FPWGFVUWXYCRQH-UHFFFAOYSA-N 0.000 claims 1
- VEKHFHMGKUQDCQ-UHFFFAOYSA-N 1-(3-bromo-4-fluorophenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(Br)C(F)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 VEKHFHMGKUQDCQ-UHFFFAOYSA-N 0.000 claims 1
- LDTAAGFKEVACHC-UHFFFAOYSA-N 1-(3-bromo-4-methoxyphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(Br)C(OC)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 LDTAAGFKEVACHC-UHFFFAOYSA-N 0.000 claims 1
- ZADWNBIFKQRSOU-UHFFFAOYSA-N 1-(3-bromo-4-methylphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(Br)C(C)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 ZADWNBIFKQRSOU-UHFFFAOYSA-N 0.000 claims 1
- DTHIVQGPJKVGPJ-UHFFFAOYSA-N 1-(3-chloro-4-fluorophenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(Cl)C(F)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 DTHIVQGPJKVGPJ-UHFFFAOYSA-N 0.000 claims 1
- KTINNEIEHISFJF-UHFFFAOYSA-N 1-(3-chloro-4-methoxyphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(Cl)C(OC)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 KTINNEIEHISFJF-UHFFFAOYSA-N 0.000 claims 1
- DHSXSHGHBPXOOY-UHFFFAOYSA-N 1-(3-chloro-4-methylphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(Cl)C(C)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 DHSXSHGHBPXOOY-UHFFFAOYSA-N 0.000 claims 1
- BBSJKVVUWIRQMG-UHFFFAOYSA-N 1-(5-bromo-2,4-difluorophenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(Br)C(F)=CC(F)=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 BBSJKVVUWIRQMG-UHFFFAOYSA-N 0.000 claims 1
- UZWMWXZSKSRTTA-UHFFFAOYSA-N 1-(5-bromo-2-ethoxyphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound CCOC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 UZWMWXZSKSRTTA-UHFFFAOYSA-N 0.000 claims 1
- SFATUYZETCDXJC-UHFFFAOYSA-N 1-(5-bromo-2-methoxy-4-methylphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC(C)=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 SFATUYZETCDXJC-UHFFFAOYSA-N 0.000 claims 1
- CPYKCKDISRLYRC-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-(pyridin-3-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=CN=C1 CPYKCKDISRLYRC-UHFFFAOYSA-N 0.000 claims 1
- HULUDHUZWWWMRQ-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-(pyridin-3-ylmethyl)indol-5-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=C(N(CC=2C=NC=CC=2)C=C2)C2=C1 HULUDHUZWWWMRQ-UHFFFAOYSA-N 0.000 claims 1
- YKINCYOSYOLSFX-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-(pyridin-4-ylmethyl)indazol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=NN2CC1=CC=NC=C1 YKINCYOSYOLSFX-UHFFFAOYSA-N 0.000 claims 1
- ONIWGOKFYOBZSC-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 ONIWGOKFYOBZSC-UHFFFAOYSA-N 0.000 claims 1
- QOVFTBYVBOLMHY-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-(pyridin-4-ylmethyl)indol-5-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=C(N(CC=2C=CN=CC=2)C=C2)C2=C1 QOVFTBYVBOLMHY-UHFFFAOYSA-N 0.000 claims 1
- ZIFGHSVKFKSDPR-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[(2-fluoropyridin-4-yl)methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(F)=C1 ZIFGHSVKFKSDPR-UHFFFAOYSA-N 0.000 claims 1
- QWBIUTWWXKGKBF-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[(2-methoxypyridin-4-yl)methyl]indol-4-yl]urea Chemical compound C1=NC(OC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Br)C=4)OC)=C3C=C2)=C1 QWBIUTWWXKGKBF-UHFFFAOYSA-N 0.000 claims 1
- GMTLBHKLWRDJHH-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[(2-methylpyridin-4-yl)methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(C)=C1 GMTLBHKLWRDJHH-UHFFFAOYSA-N 0.000 claims 1
- TXPNOGHKVNWPJQ-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[(2-morpholin-4-ylpyridin-4-yl)methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N2CCOCC2)=C1 TXPNOGHKVNWPJQ-UHFFFAOYSA-N 0.000 claims 1
- FKFGITHAQSZFRF-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[(2-oxo-1h-pyridin-4-yl)methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(O)=C1 FKFGITHAQSZFRF-UHFFFAOYSA-N 0.000 claims 1
- HVCRXOVVCFKXRR-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[(3-chloropyridin-4-yl)methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1Cl HVCRXOVVCFKXRR-UHFFFAOYSA-N 0.000 claims 1
- SVQZZMXTVZCEGS-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[(3-fluoropyridin-4-yl)methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1F SVQZZMXTVZCEGS-UHFFFAOYSA-N 0.000 claims 1
- ZJJPGXDVXQEEOT-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[[2-(2-hydroxyethylamino)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NCCO)=C1 ZJJPGXDVXQEEOT-UHFFFAOYSA-N 0.000 claims 1
- PZZKGCZXTTVKIO-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[[2-(2-methoxyethylamino)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound C1=NC(NCCOC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Br)C=4)OC)=C3C=C2)=C1 PZZKGCZXTTVKIO-UHFFFAOYSA-N 0.000 claims 1
- YUJBRBUIEUFERZ-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[[2-(methanesulfonamido)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NS(C)(=O)=O)=C1 YUJBRBUIEUFERZ-UHFFFAOYSA-N 0.000 claims 1
- GRSVWLJSKODNBT-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[[2-(methylamino)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound C1=NC(NC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Br)C=4)OC)=C3C=C2)=C1 GRSVWLJSKODNBT-UHFFFAOYSA-N 0.000 claims 1
- ARTUJNNYCCINHT-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[1-[[2-(propan-2-ylcarbamoylamino)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)NC(C)C)=C1 ARTUJNNYCCINHT-UHFFFAOYSA-N 0.000 claims 1
- YTGUWBBIBHACGN-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[3-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C(C)=CN2CC1=CC=NC=C1 YTGUWBBIBHACGN-UHFFFAOYSA-N 0.000 claims 1
- LCDKPHAKDJIZGF-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[5-chloro-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=C(Cl)C=CC2=C1C=CN2CC1=CC=NC=C1 LCDKPHAKDJIZGF-UHFFFAOYSA-N 0.000 claims 1
- HXINVQHQKKOWPT-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[5-fluoro-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=C(F)C=CC2=C1C=CN2CC1=CC=NC=C1 HXINVQHQKKOWPT-UHFFFAOYSA-N 0.000 claims 1
- BDNSJPXQXSEINJ-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[5-methoxy-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=C(OC)C=CC2=C1C=CN2CC1=CC=NC=C1 BDNSJPXQXSEINJ-UHFFFAOYSA-N 0.000 claims 1
- OGRXULSIWPKRED-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[5-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=C(C)C=CC2=C1C=CN2CC1=CC=NC=C1 OGRXULSIWPKRED-UHFFFAOYSA-N 0.000 claims 1
- XVOUFMUKQDXRMM-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[6-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC(C)=CC2=C1C=CN2CC1=CC=NC=C1 XVOUFMUKQDXRMM-UHFFFAOYSA-N 0.000 claims 1
- FNVMEZYUXHORRM-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[7-chloro-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=C(Cl)C2=C1C=CN2CC1=CC=NC=C1 FNVMEZYUXHORRM-UHFFFAOYSA-N 0.000 claims 1
- KQAWHKKFZAQQNB-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[7-fluoro-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=C(F)C2=C1C=CN2CC1=CC=NC=C1 KQAWHKKFZAQQNB-UHFFFAOYSA-N 0.000 claims 1
- FHEYVMONNUPHIK-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[7-methoxy-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=C(OC)C2=C1C=CN2CC1=CC=NC=C1 FHEYVMONNUPHIK-UHFFFAOYSA-N 0.000 claims 1
- SCGXWQTZGPCZCE-UHFFFAOYSA-N 1-(5-bromo-2-methoxyphenyl)-3-[7-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=C(C)C2=C1C=CN2CC1=CC=NC=C1 SCGXWQTZGPCZCE-UHFFFAOYSA-N 0.000 claims 1
- BXRABKOISFMUKO-UHFFFAOYSA-N 1-(5-chloro-2-methoxy-4-methylphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC(C)=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 BXRABKOISFMUKO-UHFFFAOYSA-N 0.000 claims 1
- OCSHMIVAXMBEBS-UHFFFAOYSA-N 1-(5-chloro-2-methoxy-4-methylphenyl)-3-[7-fluoro-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC(C)=C(Cl)C=C1NC(=O)NC1=CC=C(F)C2=C1C=CN2CC1=CC=NC=C1 OCSHMIVAXMBEBS-UHFFFAOYSA-N 0.000 claims 1
- XNGOAKXUOZRXHP-UHFFFAOYSA-N 1-(5-chloro-2-methoxyphenyl)-3-[1-(pyridin-4-ylmethyl)indol-5-yl]urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=C(N(CC=2C=CN=CC=2)C=C2)C2=C1 XNGOAKXUOZRXHP-UHFFFAOYSA-N 0.000 claims 1
- VDCAEBCHUGSNJK-UHFFFAOYSA-N 1-(5-chloro-2-methoxyphenyl)-3-[1-[(2-cyanopyridin-4-yl)methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(C#N)=C1 VDCAEBCHUGSNJK-UHFFFAOYSA-N 0.000 claims 1
- CVUVYJZIEHGIFH-UHFFFAOYSA-N 1-(5-chloro-2-methoxyphenyl)-3-[1-[(3-methylpyridin-4-yl)methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1C CVUVYJZIEHGIFH-UHFFFAOYSA-N 0.000 claims 1
- UFZABACKBCHKPB-UHFFFAOYSA-N 1-(5-chloro-2-methoxyphenyl)-3-[1-[[2-(1,3-thiazol-2-ylamino)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC=2SC=CN=2)=C1 UFZABACKBCHKPB-UHFFFAOYSA-N 0.000 claims 1
- BBRVGUAGUUBENF-UHFFFAOYSA-N 1-(5-chloro-2-methoxyphenyl)-3-[1-[[2-(4-cyanoanilino)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC=2C=CC(=CC=2)C#N)=C1 BBRVGUAGUUBENF-UHFFFAOYSA-N 0.000 claims 1
- ZRXMCSSZSIFTOK-UHFFFAOYSA-N 1-(5-chloro-2-methoxyphenyl)-3-[1-[[2-(methanesulfonamido)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NS(C)(=O)=O)=C1 ZRXMCSSZSIFTOK-UHFFFAOYSA-N 0.000 claims 1
- WWSTUNFETQEVAD-UHFFFAOYSA-N 1-(5-chloro-2-methoxyphenyl)-3-[1-[[2-(pyrazin-2-ylamino)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC=2N=CC=NC=2)=C1 WWSTUNFETQEVAD-UHFFFAOYSA-N 0.000 claims 1
- MQQXYSGFMMMCSP-UHFFFAOYSA-N 1-(5-chloro-2-methoxyphenyl)-3-[5-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=C(C)C=CC2=C1C=CN2CC1=CC=NC=C1 MQQXYSGFMMMCSP-UHFFFAOYSA-N 0.000 claims 1
- ZMDVNXVEKYKBPA-UHFFFAOYSA-N 1-(5-chloro-2-methoxyphenyl)-3-[7-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=C(C)C2=C1C=CN2CC1=CC=NC=C1 ZMDVNXVEKYKBPA-UHFFFAOYSA-N 0.000 claims 1
- KZSASGHRCTWDSH-UHFFFAOYSA-N 1-(5-ethylsulfonyl-2-methoxyphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound CCS(=O)(=O)C1=CC=C(OC)C(NC(=O)NC=2C=3C=CN(CC=4C=CN=CC=4)C=3C=CC=2)=C1 KZSASGHRCTWDSH-UHFFFAOYSA-N 0.000 claims 1
- BRZYFPPCBGFDOM-UHFFFAOYSA-N 1-(5-fluoro-2,4-dimethoxyphenyl)-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(F)C(OC)=CC(OC)=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 BRZYFPPCBGFDOM-UHFFFAOYSA-N 0.000 claims 1
- ILUDPKDIUKLTHL-UHFFFAOYSA-N 1-[1-[(2-amino-3-methylpyridin-4-yl)methyl]indol-4-yl]-3-(5-bromo-2-methoxyphenyl)urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1C ILUDPKDIUKLTHL-UHFFFAOYSA-N 0.000 claims 1
- BAMUBQUJNFQOMZ-UHFFFAOYSA-N 1-[1-[(2-amino-5-fluoropyridin-4-yl)methyl]indol-4-yl]-3-(5-bromo-2-methoxyphenyl)urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC(N)=NC=C1F BAMUBQUJNFQOMZ-UHFFFAOYSA-N 0.000 claims 1
- SBPJRUSUAMSHDY-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]-5-chloroindol-4-yl]-3-(5-bromo-2-methoxyphenyl)urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=C(Cl)C=CC2=C1C=CN2CC1=CC=NC(N)=C1 SBPJRUSUAMSHDY-UHFFFAOYSA-N 0.000 claims 1
- HOHBFYQYTITGRT-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]-5-fluoroindol-4-yl]-3-(2,5-dichlorophenyl)urea Chemical compound C1=NC(N)=CC(CN2C3=CC=C(F)C(NC(=O)NC=4C(=CC=C(Cl)C=4)Cl)=C3C=C2)=C1 HOHBFYQYTITGRT-UHFFFAOYSA-N 0.000 claims 1
- LQCGUOBZMOSNRK-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]-5-fluoroindol-4-yl]-3-(5-bromo-2-methoxyphenyl)urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=C(F)C=CC2=C1C=CN2CC1=CC=NC(N)=C1 LQCGUOBZMOSNRK-UHFFFAOYSA-N 0.000 claims 1
- NSEMYRFQGKPEKF-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]-5-fluoroindol-4-yl]-3-(5-chloro-2-methoxyphenyl)urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=C(F)C=CC2=C1C=CN2CC1=CC=NC(N)=C1 NSEMYRFQGKPEKF-UHFFFAOYSA-N 0.000 claims 1
- LCAAIHVTSQQSTK-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]-5-fluoroindol-4-yl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea Chemical compound C1=NC(N)=CC(CN2C3=CC=C(F)C(NC(=O)NC=4C(=CC=C(C=4)C(F)(F)F)F)=C3C=C2)=C1 LCAAIHVTSQQSTK-UHFFFAOYSA-N 0.000 claims 1
- DXZDSPXDYQWJNW-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]-5-fluoroindol-4-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]urea Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=C(F)C=CC2=C1C=CN2CC1=CC=NC(N)=C1 DXZDSPXDYQWJNW-UHFFFAOYSA-N 0.000 claims 1
- GBIRJXOQVPDSOB-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]-7-fluoroindol-4-yl]-3-(5-bromo-2-methoxyphenyl)urea Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=C(F)C2=C1C=CN2CC1=CC=NC(N)=C1 GBIRJXOQVPDSOB-UHFFFAOYSA-N 0.000 claims 1
- QLVDBFZSIMHZQC-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]-7-fluoroindol-4-yl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea Chemical compound C1=NC(N)=CC(CN2C3=C(F)C=CC(NC(=O)NC=4C(=CC=C(C=4)C(F)(F)F)F)=C3C=C2)=C1 QLVDBFZSIMHZQC-UHFFFAOYSA-N 0.000 claims 1
- QDUACQACRUCQLK-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-(3-bromo-4-methoxyphenyl)urea Chemical compound C1=C(Br)C(OC)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 QDUACQACRUCQLK-UHFFFAOYSA-N 0.000 claims 1
- UKEXULSNZMFFQW-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-(3-chloro-4-methylphenyl)urea Chemical compound C1=C(Cl)C(C)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 UKEXULSNZMFFQW-UHFFFAOYSA-N 0.000 claims 1
- LOMULLQYOJZHRS-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-(5-bromo-2-methoxy-4-methylphenyl)urea Chemical compound COC1=CC(C)=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 LOMULLQYOJZHRS-UHFFFAOYSA-N 0.000 claims 1
- QHDPRELNECVFMB-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-(5-chloro-2,4-dimethoxyphenyl)urea Chemical compound C1=C(Cl)C(OC)=CC(OC)=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 QHDPRELNECVFMB-UHFFFAOYSA-N 0.000 claims 1
- JFEFVVOHEOZTOL-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-(5-chloro-2-methoxy-4-methylphenyl)urea Chemical compound COC1=CC(C)=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 JFEFVVOHEOZTOL-UHFFFAOYSA-N 0.000 claims 1
- GPTRAPGXWSGCKJ-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-(5-chloro-2-methoxyphenyl)urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 GPTRAPGXWSGCKJ-UHFFFAOYSA-N 0.000 claims 1
- HPHNINSVVJJJHJ-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-[2,4-dimethoxy-5-(trifluoromethyl)phenyl]urea Chemical compound COC1=CC(OC)=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 HPHNINSVVJJJHJ-UHFFFAOYSA-N 0.000 claims 1
- TXUOGPCEAWQFGI-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-[2,4-dimethyl-5-(trifluoromethyl)phenyl]urea Chemical compound CC1=CC(C)=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 TXUOGPCEAWQFGI-UHFFFAOYSA-N 0.000 claims 1
- URBOIBWNZLNFKT-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea Chemical compound C1=NC(N)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(C=4)C(F)(F)F)F)=C3C=C2)=C1 URBOIBWNZLNFKT-UHFFFAOYSA-N 0.000 claims 1
- XHIODSXMABORLF-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-[2-methoxy-4-methyl-5-(trifluoromethyl)phenyl]urea Chemical compound COC1=CC(C)=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 XHIODSXMABORLF-UHFFFAOYSA-N 0.000 claims 1
- HLQVUGHYXJPWDB-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]urea Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(N)=C1 HLQVUGHYXJPWDB-UHFFFAOYSA-N 0.000 claims 1
- WGTRZNZQPKYHAZ-UHFFFAOYSA-N 1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-[5-bromo-2-(difluoromethoxy)phenyl]urea Chemical compound C1=NC(N)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Br)C=4)OC(F)F)=C3C=C2)=C1 WGTRZNZQPKYHAZ-UHFFFAOYSA-N 0.000 claims 1
- BXDKAUPSHZCHEO-UHFFFAOYSA-N 1-[1-[(2-bromopyridin-4-yl)methyl]indol-4-yl]-3-(5-chloro-2-methoxyphenyl)urea Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(Br)=C1 BXDKAUPSHZCHEO-UHFFFAOYSA-N 0.000 claims 1
- MTBAGZVMIBHZJT-UHFFFAOYSA-N 1-[1-[(2-bromopyridin-4-yl)methyl]indol-4-yl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea Chemical compound FC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(Br)=C1 MTBAGZVMIBHZJT-UHFFFAOYSA-N 0.000 claims 1
- DIPZWTGIYFHUSH-UHFFFAOYSA-N 1-[1-[(2-cyanopyridin-4-yl)methyl]indol-4-yl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea Chemical compound FC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(C#N)=C1 DIPZWTGIYFHUSH-UHFFFAOYSA-N 0.000 claims 1
- DVYBGFOYCKJSOB-UHFFFAOYSA-N 1-[1-[(3-fluoropyridin-4-yl)methyl]indol-4-yl]-3-[4-methyl-3-(trifluoromethyl)phenyl]urea Chemical compound C1=C(C(F)(F)F)C(C)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1F DVYBGFOYCKJSOB-UHFFFAOYSA-N 0.000 claims 1
- ZCLBJZPFJVOOHS-UHFFFAOYSA-N 1-[2,4-dimethoxy-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC(OC)=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 ZCLBJZPFJVOOHS-UHFFFAOYSA-N 0.000 claims 1
- ADMWECYINHHTHO-UHFFFAOYSA-N 1-[2,4-dimethoxy-5-(trifluoromethyl)phenyl]-3-[7-methoxy-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC(OC)=C(C(F)(F)F)C=C1NC(=O)NC1=CC=C(OC)C2=C1C=CN2CC1=CC=NC=C1 ADMWECYINHHTHO-UHFFFAOYSA-N 0.000 claims 1
- NMSZLMIKYUOFBH-UHFFFAOYSA-N 1-[2,4-dimethyl-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound CC1=CC(C)=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 NMSZLMIKYUOFBH-UHFFFAOYSA-N 0.000 claims 1
- BODINVSOSLSUTP-UHFFFAOYSA-N 1-[2-chloro-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-5-yl]urea Chemical compound FC(F)(F)C1=CC=C(Cl)C(NC(=O)NC=2C=C3C=CN(CC=4C=CN=CC=4)C3=CC=2)=C1 BODINVSOSLSUTP-UHFFFAOYSA-N 0.000 claims 1
- KOURTBIKKKOPAN-UHFFFAOYSA-N 1-[2-ethoxy-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound CCOC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 KOURTBIKKKOPAN-UHFFFAOYSA-N 0.000 claims 1
- SRGKGPPRCFDTPT-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound FC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 SRGKGPPRCFDTPT-UHFFFAOYSA-N 0.000 claims 1
- BETHWIXRWGMBOS-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-5-yl]urea Chemical compound FC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=C(N(CC=2C=CN=CC=2)C=C2)C2=C1 BETHWIXRWGMBOS-UHFFFAOYSA-N 0.000 claims 1
- VPYMVOHUSKAVPZ-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[1-[[2-(1h-imidazol-2-yl)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound FC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(C=2NC=CN=2)=C1 VPYMVOHUSKAVPZ-UHFFFAOYSA-N 0.000 claims 1
- DHLDLTUJNDDTCK-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[1-[[2-(2h-tetrazol-5-yl)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound FC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(C=2NN=NN=2)=C1 DHLDLTUJNDDTCK-UHFFFAOYSA-N 0.000 claims 1
- LOAMWSUGNVHLDO-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[1-[[2-(pyridin-2-ylamino)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound FC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC=2N=CC=CC=2)=C1 LOAMWSUGNVHLDO-UHFFFAOYSA-N 0.000 claims 1
- LZFNCHIOCYXQTO-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[1-[[2-(pyridin-3-ylamino)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound FC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC=2C=NC=CC=2)=C1 LZFNCHIOCYXQTO-UHFFFAOYSA-N 0.000 claims 1
- OTJVAGGOOFFPEA-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[1-[[2-(pyrimidin-2-ylamino)pyridin-4-yl]methyl]indol-4-yl]urea Chemical compound FC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC=2N=CC=CN=2)=C1 OTJVAGGOOFFPEA-UHFFFAOYSA-N 0.000 claims 1
- XHMNDDYGEZUICY-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[3-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C12=CC=CC(NC(=O)NC=3C(=CC=C(C=3)C(F)(F)F)F)=C2C(C)=CN1CC1=CC=NC=C1 XHMNDDYGEZUICY-UHFFFAOYSA-N 0.000 claims 1
- IAKQWBMHEQMUKB-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[5-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=CC2=C(NC(=O)NC=3C(=CC=C(C=3)C(F)(F)F)F)C(C)=CC=C2N1CC1=CC=NC=C1 IAKQWBMHEQMUKB-UHFFFAOYSA-N 0.000 claims 1
- JOXIUEJQYIGAPO-UHFFFAOYSA-N 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[7-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=2C=CN(CC=3C=CN=CC=3)C=2C(C)=CC=C1NC(=O)NC1=CC(C(F)(F)F)=CC=C1F JOXIUEJQYIGAPO-UHFFFAOYSA-N 0.000 claims 1
- IHDFIWGWTMLLNG-UHFFFAOYSA-N 1-[2-methoxy-4-methyl-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC(C)=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 IHDFIWGWTMLLNG-UHFFFAOYSA-N 0.000 claims 1
- HQLLTDZFHPPOMB-UHFFFAOYSA-N 1-[2-methoxy-5-(trifluoromethyl)phenyl]-3-(1-pyridin-4-ylindol-5-yl)urea Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=C(N(C=C2)C=3C=CN=CC=3)C2=C1 HQLLTDZFHPPOMB-UHFFFAOYSA-N 0.000 claims 1
- FUNLKXXAJNDCRT-UHFFFAOYSA-N 1-[2-methoxy-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 FUNLKXXAJNDCRT-UHFFFAOYSA-N 0.000 claims 1
- GFLYNPUQZKWJAQ-UHFFFAOYSA-N 1-[2-methoxy-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-5-yl]urea Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=C(N(CC=2C=CN=CC=2)C=C2)C2=C1 GFLYNPUQZKWJAQ-UHFFFAOYSA-N 0.000 claims 1
- PCVZIYRGVDCFQW-UHFFFAOYSA-N 1-[2-methoxy-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-6-yl]urea Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=C(C=CN2CC=3C=CN=CC=3)C2=C1 PCVZIYRGVDCFQW-UHFFFAOYSA-N 0.000 claims 1
- DPTPSBUQLXSYMM-UHFFFAOYSA-N 1-[2-methoxy-5-(trifluoromethyl)phenyl]-3-[3-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C(C)=CN2CC1=CC=NC=C1 DPTPSBUQLXSYMM-UHFFFAOYSA-N 0.000 claims 1
- AYAVIONWAGJVKH-UHFFFAOYSA-N 1-[2-methoxy-5-(trifluoromethyl)phenyl]-3-[5-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=C(C)C=CC2=C1C=CN2CC1=CC=NC=C1 AYAVIONWAGJVKH-UHFFFAOYSA-N 0.000 claims 1
- APOFDZYKVUXEMG-UHFFFAOYSA-N 1-[2-methoxy-5-(trifluoromethyl)phenyl]-3-[7-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=C(C)C2=C1C=CN2CC1=CC=NC=C1 APOFDZYKVUXEMG-UHFFFAOYSA-N 0.000 claims 1
- NREUFTRUVSLGJN-UHFFFAOYSA-N 1-[4-chloro-2-methoxy-5-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound COC1=CC(Cl)=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 NREUFTRUVSLGJN-UHFFFAOYSA-N 0.000 claims 1
- LNPVNQWEALVSCD-UHFFFAOYSA-N 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-(1-pyridin-4-ylindol-5-yl)urea Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=C3C=CN(C3=CC=2)C=2C=CN=CC=2)=C1 LNPVNQWEALVSCD-UHFFFAOYSA-N 0.000 claims 1
- OONGKRSRLXHIQU-UHFFFAOYSA-N 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=3C=CN(CC=4C=CN=CC=4)C=3C=CC=2)=C1 OONGKRSRLXHIQU-UHFFFAOYSA-N 0.000 claims 1
- RJAUIFUJMCXRMJ-UHFFFAOYSA-N 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-5-yl]urea Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=C3C=CN(CC=4C=CN=CC=4)C3=CC=2)=C1 RJAUIFUJMCXRMJ-UHFFFAOYSA-N 0.000 claims 1
- VNBHBBDWWITXBR-UHFFFAOYSA-N 1-[4-chloro-3-(trifluoromethyl)phenyl]-3-[7-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=2C=CN(CC=3C=CN=CC=3)C=2C(C)=CC=C1NC(=O)NC1=CC=C(Cl)C(C(F)(F)F)=C1 VNBHBBDWWITXBR-UHFFFAOYSA-N 0.000 claims 1
- IBPAJVKFBVLGRR-UHFFFAOYSA-N 1-[4-fluoro-3-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(C(F)(F)F)C(F)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 IBPAJVKFBVLGRR-UHFFFAOYSA-N 0.000 claims 1
- OZEYRVHPKXQCPT-UHFFFAOYSA-N 1-[4-methyl-3-(trifluoromethyl)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=C(C(F)(F)F)C(C)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC=C1 OZEYRVHPKXQCPT-UHFFFAOYSA-N 0.000 claims 1
- RLEUGRKSIDGIDO-UHFFFAOYSA-N 1-[5-chloro-2-(1,3-dioxolan-2-ylmethoxy)phenyl]-3-[1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C=1C=CC=2N(CC=3C=CN=CC=3)C=CC=2C=1NC(=O)NC1=CC(Cl)=CC=C1OCC1OCCO1 RLEUGRKSIDGIDO-UHFFFAOYSA-N 0.000 claims 1
- AGSHUPSOVOLTLL-UHFFFAOYSA-N 1-[5-chloro-2-(3-hydroxypropoxy)phenyl]-3-[5-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]urea Chemical compound C1=CC2=C(NC(=O)NC=3C(=CC=C(Cl)C=3)OCCCO)C(C)=CC=C2N1CC1=CC=NC=C1 AGSHUPSOVOLTLL-UHFFFAOYSA-N 0.000 claims 1
- AZNHIOJCPXYZIQ-UHFFFAOYSA-N 1-[7-methyl-1-(pyridin-4-ylmethyl)indol-4-yl]-3-[4-methyl-3-(trifluoromethyl)phenyl]urea Chemical compound C1=C(C(F)(F)F)C(C)=CC=C1NC(=O)NC1=CC=C(C)C2=C1C=CN2CC1=CC=NC=C1 AZNHIOJCPXYZIQ-UHFFFAOYSA-N 0.000 claims 1
- VCEAIMUTAHEERT-UHFFFAOYSA-N 1-phenyl-3-[3-(2-pyridin-4-ylethyl)-1h-indol-5-yl]urea Chemical compound C=1C=C2NC=C(CCC=3C=CN=CC=3)C2=CC=1NC(=O)NC1=CC=CC=C1 VCEAIMUTAHEERT-UHFFFAOYSA-N 0.000 claims 1
- RZGUIXACFQACLU-UHFFFAOYSA-N 4-[[4-[[2-methoxy-5-(trifluoromethyl)phenyl]carbamoylamino]-5-methylindol-1-yl]methyl]-n-methylpyridine-2-carboxamide Chemical compound C1=NC(C(=O)NC)=CC(CN2C3=CC=C(C)C(NC(=O)NC=4C(=CC=C(C=4)C(F)(F)F)OC)=C3C=C2)=C1 RZGUIXACFQACLU-UHFFFAOYSA-N 0.000 claims 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 1
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims 1
- 241001553014 Myrsine salicina Species 0.000 claims 1
- JPNJRUCBQNCOJX-UHFFFAOYSA-N NC(=O)NC1=C2C=CN(CC3=CC=NC=C3)C2=CC=C1 Chemical compound NC(=O)NC1=C2C=CN(CC3=CC=NC=C3)C2=CC=C1 JPNJRUCBQNCOJX-UHFFFAOYSA-N 0.000 claims 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000036952 cancer formation Effects 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000013522 chelant Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000013078 crystal Substances 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 229940012356 eye drops Drugs 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- AJAJPCNOPZDPIZ-UHFFFAOYSA-N methyl n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]carbamate Chemical compound C1=NC(NC(=O)OC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Br)C=4)OC)=C3C=C2)=C1 AJAJPCNOPZDPIZ-UHFFFAOYSA-N 0.000 claims 1
- PQIOSYKVBBWRRI-UHFFFAOYSA-N methylphosphonyl difluoride Chemical group CP(F)(F)=O PQIOSYKVBBWRRI-UHFFFAOYSA-N 0.000 claims 1
- MQSZGGUEGKYKRC-UHFFFAOYSA-N n-[4-[[4-[(3-chloro-4-methylphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]acetamide Chemical compound C1=NC(NC(=O)C)=CC(CN2C3=CC=CC(NC(=O)NC=4C=C(Cl)C(C)=CC=4)=C3C=C2)=C1 MQSZGGUEGKYKRC-UHFFFAOYSA-N 0.000 claims 1
- OKEICWSSZYJJDD-UHFFFAOYSA-N n-[4-[[4-[(3-chloro-4-methylphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]cyclopropanecarboxamide Chemical compound C1=C(Cl)C(C)=CC=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)C2CC2)=C1 OKEICWSSZYJJDD-UHFFFAOYSA-N 0.000 claims 1
- IEPMMODFAXICIE-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-1-methylimidazole-2-carboxamide Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)C=2N(C=CN=2)C)=C1 IEPMMODFAXICIE-UHFFFAOYSA-N 0.000 claims 1
- UISMOGMDAKUXCE-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-2-(dimethylamino)acetamide Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)CN(C)C)=C1 UISMOGMDAKUXCE-UHFFFAOYSA-N 0.000 claims 1
- PVYUFDMJTULNPU-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-2-(methylamino)acetamide Chemical compound C1=NC(NC(=O)CNC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Br)C=4)OC)=C3C=C2)=C1 PVYUFDMJTULNPU-UHFFFAOYSA-N 0.000 claims 1
- SIROTSYUCGCPTK-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-2-hydroxyacetamide Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)CO)=C1 SIROTSYUCGCPTK-UHFFFAOYSA-N 0.000 claims 1
- IRZZMUCPCJTYRL-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-2-methoxyacetamide Chemical compound C1=NC(NC(=O)COC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Br)C=4)OC)=C3C=C2)=C1 IRZZMUCPCJTYRL-UHFFFAOYSA-N 0.000 claims 1
- FUSABTAFEIOLFH-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-2-methylpropanamide Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)C(C)C)=C1 FUSABTAFEIOLFH-UHFFFAOYSA-N 0.000 claims 1
- PHHNMTKUGSBZQV-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-2-morpholin-4-ylacetamide Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)CN2CCOCC2)=C1 PHHNMTKUGSBZQV-UHFFFAOYSA-N 0.000 claims 1
- UBCKVZJPRAKVDU-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-2-pyrrolidin-1-ylacetamide Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)CN2CCCC2)=C1 UBCKVZJPRAKVDU-UHFFFAOYSA-N 0.000 claims 1
- UOKPGGOJVXZTOM-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-3-(diethylamino)propanamide Chemical compound C1=NC(NC(=O)CCN(CC)CC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Br)C=4)OC)=C3C=C2)=C1 UOKPGGOJVXZTOM-UHFFFAOYSA-N 0.000 claims 1
- BUVVREQLRRRLQF-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]acetamide Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(C)=O)=C1 BUVVREQLRRRLQF-UHFFFAOYSA-N 0.000 claims 1
- DESZFQQRSWTNKO-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]cyclopropanecarboxamide Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)C2CC2)=C1 DESZFQQRSWTNKO-UHFFFAOYSA-N 0.000 claims 1
- FCDLTRRRVZNJAR-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]formamide Chemical compound COC1=CC=C(Br)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC=O)=C1 FCDLTRRRVZNJAR-UHFFFAOYSA-N 0.000 claims 1
- CVPZGGJMRTYSRL-UHFFFAOYSA-N n-[4-[[4-[(5-bromo-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]propanamide Chemical compound C1=NC(NC(=O)CC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Br)C=4)OC)=C3C=C2)=C1 CVPZGGJMRTYSRL-UHFFFAOYSA-N 0.000 claims 1
- FAKLPVXVBMSKPQ-UHFFFAOYSA-N n-[4-[[4-[(5-chloro-2-methoxy-4-methylphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]acetamide Chemical compound COC1=CC(C)=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(C)=O)=C1 FAKLPVXVBMSKPQ-UHFFFAOYSA-N 0.000 claims 1
- FGLAISSCRCJXHN-UHFFFAOYSA-N n-[4-[[4-[(5-chloro-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-2-(methylamino)acetamide Chemical compound C1=NC(NC(=O)CNC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Cl)C=4)OC)=C3C=C2)=C1 FGLAISSCRCJXHN-UHFFFAOYSA-N 0.000 claims 1
- SINNDLBFBMOQRE-UHFFFAOYSA-N n-[4-[[4-[(5-chloro-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-2-morpholin-4-ylacetamide Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)CN2CCOCC2)=C1 SINNDLBFBMOQRE-UHFFFAOYSA-N 0.000 claims 1
- VVYVEDFYSRXISP-UHFFFAOYSA-N n-[4-[[4-[(5-chloro-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-3-(diethylamino)propanamide Chemical compound C1=NC(NC(=O)CCN(CC)CC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Cl)C=4)OC)=C3C=C2)=C1 VVYVEDFYSRXISP-UHFFFAOYSA-N 0.000 claims 1
- LRPMOUJSDVQWBZ-UHFFFAOYSA-N n-[4-[[4-[(5-chloro-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]acetamide Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(C)=O)=C1 LRPMOUJSDVQWBZ-UHFFFAOYSA-N 0.000 claims 1
- NSOJCRGBVPOADB-UHFFFAOYSA-N n-[4-[[4-[(5-chloro-2-methoxyphenyl)carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]cyclopropanecarboxamide Chemical compound COC1=CC=C(Cl)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)C2CC2)=C1 NSOJCRGBVPOADB-UHFFFAOYSA-N 0.000 claims 1
- MIRIZLBZGQKGKX-UHFFFAOYSA-N n-[4-[[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]-2-(methylamino)acetamide Chemical compound C1=NC(NC(=O)CNC)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(C=4)C(F)(F)F)F)=C3C=C2)=C1 MIRIZLBZGQKGKX-UHFFFAOYSA-N 0.000 claims 1
- INGQXNFQBHSVDC-UHFFFAOYSA-N n-[4-[[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]acetamide Chemical compound C1=NC(NC(=O)C)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(C=4)C(F)(F)F)F)=C3C=C2)=C1 INGQXNFQBHSVDC-UHFFFAOYSA-N 0.000 claims 1
- IZELTQQMSQVHNI-UHFFFAOYSA-N n-[4-[[4-[[2-fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]cyclopropanecarboxamide Chemical compound FC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)C2CC2)=C1 IZELTQQMSQVHNI-UHFFFAOYSA-N 0.000 claims 1
- PQKJVXXAJNEJFE-UHFFFAOYSA-N n-[4-[[4-[[2-methoxy-5-(trifluoromethyl)phenyl]carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]cyclopropanecarboxamide Chemical compound COC1=CC=C(C(F)(F)F)C=C1NC(=O)NC1=CC=CC2=C1C=CN2CC1=CC=NC(NC(=O)C2CC2)=C1 PQKJVXXAJNEJFE-UHFFFAOYSA-N 0.000 claims 1
- FHVCLBVTZRQYRN-UHFFFAOYSA-N n-[4-[[4-[[5-bromo-2-(difluoromethoxy)phenyl]carbamoylamino]indol-1-yl]methyl]pyridin-2-yl]acetamide Chemical compound C1=NC(NC(=O)C)=CC(CN2C3=CC=CC(NC(=O)NC=4C(=CC=C(Br)C=4)OC(F)F)=C3C=C2)=C1 FHVCLBVTZRQYRN-UHFFFAOYSA-N 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000005415 substituted alkoxy group Chemical group 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001425 triazolyl group Chemical group 0.000 claims 1
- 0 CCCCC(C)C(/C=C/C1*)(/C=C/C(*)(C(C)C)C1I)N(*)C(N(*)*)=O Chemical compound CCCCC(C)C(/C=C/C1*)(/C=C/C(*)(C(C)C)C1I)N(*)C(N(*)*)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64388605P | 2005-01-14 | 2005-01-14 | |
| US73299905P | 2005-11-02 | 2005-11-02 | |
| PCT/US2006/001272 WO2006076593A1 (en) | 2005-01-14 | 2006-01-13 | 1,3-diaryl substituted ureas as modulators of kinase activity |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012208429A Division JP2013028628A (ja) | 2005-01-14 | 2012-09-21 | キナーゼ活性モジュレーターとしての１，３−ジアリール置換尿素 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526988A JP2008526988A (ja) | 2008-07-24 |
| JP2008526988A5 true JP2008526988A5 (enExample) | 2010-12-16 |
Family
ID=36250833
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007551409A Pending JP2008526988A (ja) | 2005-01-14 | 2006-01-13 | キナーゼ活性モジュレーターとしての１，３−ジアリール置換尿素 |
| JP2012208429A Pending JP2013028628A (ja) | 2005-01-14 | 2012-09-21 | キナーゼ活性モジュレーターとしての１，３−ジアリール置換尿素 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012208429A Pending JP2013028628A (ja) | 2005-01-14 | 2012-09-21 | キナーゼ活性モジュレーターとしての１，３−ジアリール置換尿素 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060199846A1 (enExample) |
| EP (2) | EP1858879B1 (enExample) |
| JP (2) | JP2008526988A (enExample) |
| KR (1) | KR101292598B1 (enExample) |
| CN (1) | CN102267978A (enExample) |
| AU (1) | AU2006204790B2 (enExample) |
| CA (1) | CA2594449A1 (enExample) |
| ES (1) | ES2393741T3 (enExample) |
| IL (1) | IL184494A (enExample) |
| NZ (1) | NZ556433A (enExample) |
| RU (1) | RU2402544C2 (enExample) |
| TW (1) | TWI378925B (enExample) |
| WO (1) | WO2006076593A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060199846A1 (en) * | 2005-01-14 | 2006-09-07 | Mitchell Scott A | Certain substituted ureas as modulators of kinase activity |
| WO2007024294A2 (en) * | 2005-05-03 | 2007-03-01 | Cgi Pharmaceuticals, Inc. | Certain substituted ureas, as modulators of kinase activity |
| ES2378704T3 (es) * | 2006-01-27 | 2012-04-17 | Array Biopharma, Inc. | Activadores de la glucocinasa |
| CN101058561B (zh) * | 2006-04-19 | 2011-01-26 | 苏州爱斯鹏药物研发有限责任公司 | 用于抑制蛋白激酶的二苯脲衍生物及其组合物和用途 |
| JP2011520809A (ja) * | 2008-05-05 | 2011-07-21 | アムジエン・インコーポレーテツド | γセクレターゼモジュレーターとしての尿素化合物 |
| GB0812969D0 (en) | 2008-07-15 | 2008-08-20 | Sentinel Oncology Ltd | Pharmaceutical compounds |
| WO2010036316A1 (en) * | 2008-09-24 | 2010-04-01 | Yangbo Feng | Urea and carbamate compounds and analogs as kinase inhibitors |
| PH12012500366A1 (en) | 2009-08-24 | 2012-10-22 | Ascepion Pharmaceuticals Inc | 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| CN103288684B (zh) * | 2013-05-03 | 2014-12-10 | 西安交通大学 | 一种具有抗肿瘤活性的联苯脲化合物及其制备方法 |
| KR20170007311A (ko) * | 2014-05-28 | 2017-01-18 | 노파르티스 아게 | 신규 피라졸로 피리미딘 유도체 및 malt1 억제제로서의 그의 용도 |
| CN104725319A (zh) * | 2015-03-11 | 2015-06-24 | 西安交通大学 | 一种具有抗肿瘤活性的1h-吲唑-3-氨基联苯脲类化合物及其制备方法和应用 |
| US20230092163A1 (en) * | 2019-06-14 | 2023-03-23 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| CN113527254B (zh) * | 2021-07-07 | 2022-05-03 | 北京华氏信华科生物科技有限公司 | 7-甲氧基-1h-吲哚类化合物、制备方法、药物组合物及应用 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4301169A (en) * | 1978-11-14 | 1981-11-17 | Eisai Co., Ltd. | Novel imidazole compound and anti-depressing agent containing the same |
| US5395817A (en) * | 1992-01-22 | 1995-03-07 | Imperial Chemical Industries Plc | N-arylindoles and their use as herbicides |
| US5508288A (en) * | 1992-03-12 | 1996-04-16 | Smithkline Beecham, P.L.C. | Indole derivatives as 5HT1C antagonists |
| DE4327027A1 (de) * | 1993-02-15 | 1994-08-18 | Bayer Ag | Imidazoazine |
| DE4337611A1 (de) * | 1993-11-04 | 1995-05-11 | Boehringer Ingelheim Kg | Neue Benzoylguanidine, ihre Herstellung und ihre Verwendung in Arzneimitteln |
| US5593997A (en) * | 1995-05-23 | 1997-01-14 | Pfizer Inc. | 4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors |
| US5773459A (en) * | 1995-06-07 | 1998-06-30 | Sugen, Inc. | Urea- and thiourea-type compounds |
| US5807876A (en) * | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
| TR199802136T2 (xx) * | 1996-04-23 | 2001-06-21 | Vertex Pharmaceuticals Incorporated | �MPDH enzimi inhibit�rleri olarak �re t�revleri. |
| WO1997048697A1 (en) * | 1996-06-19 | 1997-12-24 | Rhone-Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| EP1449834A3 (en) * | 1997-12-22 | 2004-12-22 | Bayer Corporation | Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| EP1047418B1 (en) * | 1997-12-22 | 2005-07-27 | Bayer Pharmaceuticals Corp. | Inhibition of raf kinase using substituted heterocyclic ureas |
| US6858577B1 (en) * | 1999-06-29 | 2005-02-22 | Ortho-Mcneil Pharmaceutical, Inc. | Indole peptidomimetics as thrombin receptor antagonists |
| US6627647B1 (en) * | 2000-03-23 | 2003-09-30 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 1-(4-aminophenyl)imidazoles and their use as anti-inflammatory agents |
| US6645990B2 (en) * | 2000-08-15 | 2003-11-11 | Amgen Inc. | Thiazolyl urea compounds and methods of uses |
| US20030073692A1 (en) * | 2001-08-07 | 2003-04-17 | Pharmacia & Upjohn S.P.A. | Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| DE10139416A1 (de) * | 2001-08-17 | 2003-03-06 | Aventis Pharma Gmbh | Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| WO2003072541A2 (en) * | 2001-09-27 | 2003-09-04 | Smithkline Beecham Corporation | Chemical compounds |
| US6903104B2 (en) * | 2001-12-06 | 2005-06-07 | National Health Research Institutes | Indol-3-YL-2-oxoacetamide compounds and methods of use thereof |
| US7528165B2 (en) * | 2001-12-13 | 2009-05-05 | National Health Research Institutes | Indole compounds |
| US6933316B2 (en) * | 2001-12-13 | 2005-08-23 | National Health Research Institutes | Indole compounds |
| US7838541B2 (en) * | 2002-02-11 | 2010-11-23 | Bayer Healthcare, Llc | Aryl ureas with angiogenesis inhibiting activity |
| US20050124620A1 (en) * | 2002-04-09 | 2005-06-09 | Martyn Frederickson | Pharmaceutical compounds |
| AU2003224257A1 (en) * | 2002-04-09 | 2003-10-27 | Astex Technology Limited | Heterocyclic compounds and their use as modulators of p38 map kinase |
| JP2005530739A (ja) * | 2002-04-19 | 2005-10-13 | セルラー ジェノミクス，インコーポレーテッド | イミダゾ［１，２−ａ］ピラジン−８−イルアミン、生成方法、および使用方法 |
| WO2004022562A1 (en) * | 2002-09-09 | 2004-03-18 | Cellular Genomics, Inc. | 6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF |
| KR20060010709A (ko) * | 2002-09-23 | 2006-02-02 | 쉐링 코포레이션 | 사이클린 의존성 키나제 억제제로서의 신규한 이미다조피라진 |
| JP4799864B2 (ja) * | 2002-09-23 | 2011-10-26 | シェーリング コーポレイション | サイクリン依存性キナーゼインヒビターとしてのイミダゾピラジン |
| US7160885B2 (en) * | 2003-02-10 | 2007-01-09 | Cgi Pharmaceuticals, Inc. | Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity |
| US7157460B2 (en) * | 2003-02-20 | 2007-01-02 | Sugen Inc. | Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
| US7186832B2 (en) * | 2003-02-20 | 2007-03-06 | Sugen Inc. | Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
| US20040235892A1 (en) * | 2003-05-22 | 2004-11-25 | Yujia Dai | Indazole and benzisoxazole kinase inhibitors |
| US7405295B2 (en) * | 2003-06-04 | 2008-07-29 | Cgi Pharmaceuticals, Inc. | Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| US20060183746A1 (en) * | 2003-06-04 | 2006-08-17 | Currie Kevin S | Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| WO2005005429A1 (en) * | 2003-06-30 | 2005-01-20 | Cellular Genomics, Inc. | Certain heterocyclic substituted imidazo[1,2-a]pyrazin-8-ylamines and methods of inhibition of bruton’s tyrosine kinase by such compounds |
| WO2005019220A2 (en) * | 2003-08-11 | 2005-03-03 | Cellular Genomics Inc. | Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity |
| US20050288295A1 (en) * | 2003-11-11 | 2005-12-29 | Currie Kevin S | Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof |
| US20060199846A1 (en) * | 2005-01-14 | 2006-09-07 | Mitchell Scott A | Certain substituted ureas as modulators of kinase activity |
| WO2006076592A1 (en) * | 2005-01-14 | 2006-07-20 | Cgi Pharmaceuticals, Inc. | 1,3 substituted diaryl ureas as modulators of kinase activity |
| WO2007024294A2 (en) * | 2005-05-03 | 2007-03-01 | Cgi Pharmaceuticals, Inc. | Certain substituted ureas, as modulators of kinase activity |
-
2006
- 2006-01-13 US US11/331,346 patent/US20060199846A1/en not_active Abandoned
- 2006-01-13 TW TW095101448A patent/TWI378925B/zh not_active IP Right Cessation
- 2006-01-13 NZ NZ556433A patent/NZ556433A/en not_active IP Right Cessation
- 2006-01-13 AU AU2006204790A patent/AU2006204790B2/en not_active Ceased
- 2006-01-13 RU RU2007130895/04A patent/RU2402544C2/ru not_active IP Right Cessation
- 2006-01-13 EP EP06718359A patent/EP1858879B1/en not_active Expired - Lifetime
- 2006-01-13 CN CN2011101127260A patent/CN102267978A/zh active Pending
- 2006-01-13 JP JP2007551409A patent/JP2008526988A/ja active Pending
- 2006-01-13 KR KR1020077018205A patent/KR101292598B1/ko not_active Expired - Fee Related
- 2006-01-13 EP EP11181551A patent/EP2397478A1/en not_active Withdrawn
- 2006-01-13 WO PCT/US2006/001272 patent/WO2006076593A1/en not_active Ceased
- 2006-01-13 CA CA002594449A patent/CA2594449A1/en not_active Abandoned
- 2006-01-13 ES ES06718359T patent/ES2393741T3/es not_active Expired - Lifetime
-
2007
- 2007-07-09 IL IL184494A patent/IL184494A/en not_active IP Right Cessation
-
2012
- 2012-09-21 JP JP2012208429A patent/JP2013028628A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2345070C2 (ru) | Производные аминоиндазолов в качестве лекарственных средств, способ их получения и содержащие их фармацевтические композиции | |
| CN102271682B (zh) | 用于治疗疼痛的p2x3受体拮抗剂 | |
| JP6461637B2 (ja) | トリアジン化合物及びその医薬用途 | |
| JP6454418B2 (ja) | ピラゾール誘導体、またはその薬理学的に許容される塩 | |
| JP2008526988A5 (enExample) | ||
| JP2016506964A5 (ja) | ナトリウムチャネルの調節剤としてのキノリンおよびキノキサリンアミド | |
| JP2012510989A5 (enExample) | ||
| DK3009426T3 (en) | 4-ALKYNYL-IMIDAZOLE DERIVATIVE AND MEDICINE COMPREHENSIVE AS AN ACTIVE INGREDIENT | |
| JP2004504301A5 (enExample) | ||
| RU2012116877A (ru) | Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы | |
| US20070276011A1 (en) | Plasminogen Activator Inhibitor-1 Inhibitor | |
| JPWO2008007780A1 (ja) | ペンタジエナミド誘導体 | |
| TWI794844B (zh) | 包含經由鏈接子連接之2或更多芳基或雜芳基的新穎羰基亞肼基二氰化物化合物及其用途 | |
| RU2007130895A (ru) | 1, 3-диарилзамещенные мочевины как модуляторы киназной активности | |
| WO2010137350A1 (ja) | 神経栄養因子の活性が関与する疾患の治療または予防剤 | |
| WO2004078723A1 (ja) | ４－ピリジルアルキルチオ基を置換基として有する新規化合物 | |
| CN103228643A (zh) | 作为组胺h4受体配体的新颖苯并唑衍生物 | |
| GB2513403A (en) | WNT pathway modulators | |
| JP6228667B2 (ja) | 新規な抗真菌性オキソジヒドロピリジンカルボヒドラジド誘導体 | |
| JP6216326B2 (ja) | 炎症および癌の処置において有用なビスアリールスルホンアミド | |
| TW201602089A (zh) | 多環性ｈｅｒｇ活化劑 | |
| US9371314B2 (en) | Pyridyl benzothiophenes as kinase inhibitors | |
| JP6654614B2 (ja) | Ｔｒｐｍ８阻害薬 | |
| JP6986955B2 (ja) | ピラゾール誘導体の製造方法 | |
| TW200422293A (en) | Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |